| abstract |
The invention relates to novel substituted pyrrolidines of general formula (I), wherein A, X, B and R<SUP>1</SUP> to R<SUP>9</SUP> are such as defined in the claim 1, and to the tautomers, enantiomers, diastereomers, mixtures and the salts thereof, in particular, the salts thereof physiologically compatible with acids or organic or inorganic bases, wherein said compounds exhibit antithrombotic and Xa-inhibiting actions. |